Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Özlem Akbal-Dağıstan"'
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1509 (2023)
Aprepitant is the first member of a relatively new antiemetic drug class called NK1 receptor antagonists. It is commonly prescribed to prevent chemotherapy-induced nausea and vomiting. Although it is included in many treatment guidelines, its poor so
Externí odkaz:
https://doaj.org/article/896e8cefeffc4d17ad10e2169d10e433
Autor:
Derya Arslan, Özlem Akbal Dağıstan, Olcay Sagirli, Lutfiye Mulazimoglu, Erdal Cevher, Ayca Yildiz-Pekoz
© 2022, The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.Buccal film formulations, including antifungal nystatin, anti-inflammatory agent hydrocortisone acetate, and local anesthetic lidocaine hydrochloride
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bec22c8166274f8ff1bde808b53f34c
https://hdl.handle.net/11424/284670
https://hdl.handle.net/11424/284670
Autor:
Nilay Tarhan, Miray Arslan, Onur Kabaş, Elif Ulutaş Deniz, Bilge Sözen Şahne, Özlem Akbal Dağıstan
Publikováno v:
Turk J Pharm Sci
OBJECTIVES: Colleague solidarity, which emphasizes trust, independent thinking skills, and sharing, enables the problems encountered in the health service delivery to be dealt with effectively. This study aims to identify the current situation regard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::732bfef57bbba5eafb69f41835e87907
https://avesis.yyu.edu.tr/publication/details/9329d4fc-5d21-4364-9901-93f45d7efbf2/oai
https://avesis.yyu.edu.tr/publication/details/9329d4fc-5d21-4364-9901-93f45d7efbf2/oai
Pharmaceutical Track and Trace System (PTTS) is a successful implementation of Track and Trace approach which has been applied since 2010 in Turkey. Briefly, it defines the infrastructure framework for all units belonging to each product and works by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1869d6dc45e0135d6ccb00f7c8558a86
https://avesis.yyu.edu.tr/publication/details/8b45d312-c723-4401-b4f7-76702205e462/oai
https://avesis.yyu.edu.tr/publication/details/8b45d312-c723-4401-b4f7-76702205e462/oai
Autor:
Ozlem Akbal-Dagistan, Mustafa Sevim, Leyla Semiha Sen, Nur Sena Basarir, Meltem Culha, Aybige Erturk, Hanan Fael, Engin Kaptan, Serap Sancar, Lutfiye Mulazimoglu Durmusoglu, Berrak C. Yegen, Ayca Yildiz-Pekoz
Publikováno v:
Pharmaceutics, Vol 14, Iss 11, p 2375 (2022)
Favipiravir displays a rapid viral clearance, a high recovery rate and broad therapeutic safety; however, its oral administration was associated with systemic side effects in susceptible patients. Considering that the pulmonary route could provide a
Externí odkaz:
https://doaj.org/article/a405212c83bd41d2b88449c959d06126
Autor:
Mustafa Erelel, Mert Kaskal, Ozlem Akbal-Dagistan, Halim Issever, Ahmet Serhan Dagistanli, Hilal Balkanci, Merve Sinem Oguz, Aygun Qarayeva, Meltem Culha, Aybige Erturk, Nur Sena Basarir, Gokben Sahin, Ali Yagiz Uresin, Ahmet Ogul Araman, Alpay Medetalibeyoglu, Tufan Tukek, Mustafa Oral Oncul, Ayca Yildiz-Pekoz
Publikováno v:
Pharmaceutics, Vol 13, Iss 11, p 1768 (2021)
In COVID-19-induced acute respiratory distress syndrome, the lungs are incapable of filling with sufficient air, leading to hypoxemia that results in high mortality among hospitalized patients. In clinical trials, low-molecular-weight heparin was adm
Externí odkaz:
https://doaj.org/article/19984ebfb6c54daa9d40a18bd3016123